What is ACUR stock price today?

Visit our real-time dashboard for the current ACUR stock price and live market data.

Is ACUR stock going up or down today?

ACUR stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ACUR stock now?

The decision to buy ACUR depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ACUR a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ACUR based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ACUR stock overvalued or undervalued?

Use our DCF valuation calculator to determine if ACUR is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is ACUR's P/E ratio?

P/E ratio data for ACUR will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is ACUR's market cap?

ACUR (Acura Pharmaceuticals Inc) has a market capitalization of $0.00 billion, making it a small-cap stock.

What is ACUR's price to book ratio?

Price-to-book ratio for ACUR is available on our dashboard along with other valuation metrics.

Does ACUR pay dividends?

ACUR does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is ACUR's dividend yield?

ACUR does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is ACUR stock a good long-term investment?

ACUR's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ACUR's revenue growth rate?

Revenue growth data for ACUR is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ACUR are available on our dashboard with complete income statement analysis.

What are the risks of investing in ACUR?

Key risks for ACUR include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ACUR compare to its competitors?

Compare ACUR to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACUR's performance and positioning.

What is ACUR's stock price target for 2026?

Visit our prediction page for AI-powered price targets for ACUR with bull, base, and bear case scenarios.

What do analysts say about ACUR?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACUR. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ACUR's next earnings report?

ACUR reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ACUR - Acura Pharmaceuticals Inc

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About Acura Pharmaceuticals Inc

Acura Pharmaceuticals Inc (ACUR) common stock

Price Chart

Loading chart...

ACUR Key Statistics

Market Cap

$1.31M

How ACUR Compares to Peers

ACUR is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ACUR(This stock)	$1.31M	N/A	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 4:18 PM EDT

Ready to invest in ACUR?

Commission-free trading available. Affiliate links.

Upcoming Events for ACUR

Dashboard

Enter a ticker to analyze